These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10504820)

  • 1. Case series: clonidine has no systematic effects on PR or QTc intervals in children.
    Kofoed L; Tadepalli G; Oesterheld JR; Awadallah S; Shapiro R
    J Am Acad Child Adolesc Psychiatry; 1999 Sep; 38(9):1193-6. PubMed ID: 10504820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR
    Postgrad Med; 2010 Sep; 122(5):78-87. PubMed ID: 20861591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
    Broderick-Cantwell JJ
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):95-8. PubMed ID: 9893422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 6. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
    Connor DF; Fletcher KE; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1551-9. PubMed ID: 10596256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stimulants.
    Wilens TE; Biederman J
    Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
    Childress AC; Sallee FR
    Drugs Today (Barc); 2012 Mar; 48(3):207-17. PubMed ID: 22462040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.
    Steingard RJ; Goldberg M; Lee D; DeMaso DR
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):394-9. PubMed ID: 8169185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 13. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution.
    Ghuman JK; Ginsburg GS; Subramaniam G; Ghuman HS; Kau AS; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):516-24. PubMed ID: 11349695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.
    Nair V; Mahadevan S
    J Trop Pediatr; 2009 Apr; 55(2):116-21. PubMed ID: 19203986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine.
    St Dennis C; Synoground G
    J Sch Nurs; 1995 Dec; 11(4):9-12. PubMed ID: 8704379
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of clonidine response in Tourette syndrome: implications and inferences.
    Lichter DG; Jackson LA
    J Child Neurol; 1996 Mar; 11(2):93-7. PubMed ID: 8881983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of clonidine in children with autism spectrum disorders.
    Ming X; Gordon E; Kang N; Wagner GC
    Brain Dev; 2008 Aug; 30(7):454-60. PubMed ID: 18280681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.